Author

Zheng-Fei Zhu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Synergistic effects and clinical utilization of radioimmunotherapy for brain metastases from driver mutation‐negative non‐small cell lung cancer

Abstract Brain metastasis (BM) is a common complication of advanced non‐small cell lung cancer (NSCLC). Although immune checkpoint inhibitors (ICIs) have demonstrated efficacy in treating NSCLC‐BM, their clinical benefits are often limited. The combination of radiotherapy (RT) and ICIs has emerged as a promising strate...

Silai Yu, J. Ni, Hong-Ru Chen et al. · Precision Radiation Oncology · 0 citations

Review Open access Oct 2026

Efficacy and safety of narlumosbart in combination with stereotactic body radiation therapy followed by first-line chemotherapy combined with immunotherapy in advanced driver gene-negative non-small cell lung cancer patients with bone metastases: a phase II, single-arm, single-centre clinical trial

Abstract Introduction Immunotherapy in combination with chemotherapy has been recommended as the first-line treatment of driver gene-negative advanced non-small cell lung cancer (NSCLC), but the efficacy is reduced in NSCLC patients with bone metastases due to the immunosuppressive microenvironment. Both nuclear factor...

Jin Li, Nian-Lan Zhou, Sai-Quan Lu et al. · BMJ Open · 0 citations

Open access Sep 2026

Transmembrane glycoprotein BSG serves a dual role as a prognostic and immunological modulator in the tumor microenvironment of lung adenocarcinoma

Experimental validation confirms BSG's protein expression and prognostic relevance in LUAD and indicates that high BSG expression is an independent prognostic factor for poor survival in LUAD.

Xiao-Fei Zhang, Q. Peng, Wen-Lang Zhu et al. · Translational Oncology · 0 citations